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Leukemiactivate trithorax-group proteins, Hox transcription factors and TALE-class Hox
cofactors promote leukemogenesis, but their target genes critical for leukemogenesis remain largely
unknown. Through genetic analyses in C. elegans, we ﬁnd that the trithorax-group gene lin-59 and the TALE-
class Hox cofactor unc-62 are required for survival of the VC motor neurons. With the goal of providing a
model for how aberrantly active Hox complexes might promote leukemia, we elucidate the mechanism
through which these new inhibitors of programmed cell death act: lin-59 maintains transcription of the Hox
gene lin-39, while unc-62 promotes nuclear localization of the TALE-class Hox cofactor ceh-20. A LIN-39/
CEH-20 complex binds the promoter of the pro-apoptotic BH3-only gene egl-1, repressing its transcription
and ensuring survival of the VC neurons. In the absence of this regulatory mechanism, egl-1 is transcribed
and the VC neurons die. Furthermore, ectopic expression of the Hox gene lin-39, as occurs for human Hox
genes in leukemia, is sufﬁcient to block death of some cells. This work identiﬁes BH3-only pro-apoptotic
genes as targets of Hox-mediated repression and suggests that aberrant activation of Hox networks may
promote leukemia in part by inhibiting apoptosis.
© 2009 Elsevier Inc. All rights reserved.IntroductionProgrammed cell death, or apoptosis, is an evolutionarily conserved
mechanism for safely removing unneeded or damaged cells from an
organism. The genetic basis for programmed cell death was ﬁrst
discovered in the nematode Caenorhabditis elegans (Ellis and Horvitz,
1986), and the detailed description of a genetic pathway for
programmed cell death in this organism provided an essential
foundation for understanding the very similar but more complex
pathways ofmammals (Danial andKorsmeyer, 2004). A core pathway of
four genes executes apoptosis in C. elegans (Metzstein et al., 1998). The
Bcl-2 homolog CED-9 promotes cell survival by inhibiting the Apaf-1
homolog CED-4 (Hengartner et al., 1992; Hengartner and Horvitz, 1994;
Spector et al., 1997). Apoptosis is initiated in many cells when the BH3-
only protein EGL-1 relieves this inhibition, allowing CED-4/Apaf-1 to
activate the caspase CED-3, which kills the cell (Conradt and Horvitz,
1998; Shaham and Horvitz, 1996; Wu et al., 1997). (To aid readers, we
identify C. elegans genes and proteins by their name followed by the
name of the homologous mammalian molecule or family.)
Comparatively much less is known about how individual cells of C.
elegans decide whether to survive or undergo programmed cell death,
although it is clear that direct transcriptional regulation of core
pathway genes has a central role (Conradt and Horvitz, 1999; Liu et al.,
2006; Maurer et al., 2007; Metzstein et al., 1996; Metzstein and(S. Cameron).
l rights reserved.Horvitz, 1999; Park et al., 2006; Thellmann et al., 2003). Because C.
elegans develops in an essentially invariant pattern, it has been
possible to identify and study pathways that regulate the survival or
death of individual cells. In at least one case, a pathway that regulates
cell death and survival in speciﬁc cells of C. elegans is evolutionarily
conserved and important for the survival of human cancer cells (Inaba
et al., 1996, 1992; Inukai et al., 1999). This is consistent with cancer
cells ensuring their survival by co-opting developmental pathways
that normally regulate programmed cell death.
Gain-of-function mutations affecting Hox gene function are among
the most common mutations identiﬁed in human leukemias. Most
notably, chromosomal translocations that aberrantly activate the
Trithorax homolog MLL are common in particularly aggressive forms
of acute lymphoblastic and acute myeloid leukemia (Grimwade et al.,
1998; Pui et al., 2004), and increased activity of particular Hox genes
mediate important aspects of MLL action in humans and in mouse
models (Armstrong et al., 2002; Drabkin et al., 2002; Ferrando et al.,
2003; Krivtsov et al., 2006; Rozovskaia et al., 2003; Somervaille and
Cleary, 2006; Yeoh et al., 2002). Despite intensive study of the critical
roles of Hox proteins, cofactors, and their regulators in leukemogen-
esis, the biologically relevant target genes regulated by Hox proteins
that contribute to the malignant phenotype remain largely unknown.
Acute inhibition of HoxA9 in MLL-rearranged leukemia induces
apoptosis, indicating that one role of Hox overexpression in this
leukemia is to prevent cell death (Faber et al., in press); themechanism
through which HoxA9 ensures cell survival in this setting is unknown.
We have previously reported direct transcriptional regulation of egl-1/
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(Liu et al., 2006). In this case, the Hox protein MAB-5 and the TALE-
class Hox cofactor CEH-20 bind directly to a regulatory element of egl-
1/BH3 to induce egl-1 transcription and programmed cell death. This
suggests that cell death genes could represent Hox targets critical for
leukemogenesis. However, in this example from C. elegans and a
similar example in Drosophila (Lohmann et al., 2002), cell death is
initiated by Hox activity; suppression of programmed cell deathwould
be more consistent with promoting cancer. We therefore investigated
themechanism throughwhich theHoxprotein LIN-39 ensures survival
of speciﬁc cells of C. elegans (Clark et al., 1993) with the goal of
presenting a model for how abnormally active Hox activity might
promote cancer.
In this study, we identify two new repressors of programmed cell
death that further extend the correlation between genes that regulate
death in C. elegans and human counterparts that are oncogenes. We
identify lin-59/Ash1 (a trithorax-like gene), and unc-62/Meis (a TALE-
class Hox cofactor) as being essential for preventing programmed cell
death of speciﬁc cells in the developing ventral nerve cord, and elucidate
the mechanism through which they ensure cell survival. Our ﬁndings
suggest that developmental regulation of programmed cell death
includes direct transcriptional repression of pro-apoptotic BH3-only
genes, and that overexpressed or ectopically expressed Hox proteins
may co-opt the mechanism described here to promote oncogenesis.
Materials and methods
Genetics and lineage analysis
All strains were derived from Bristol N2 wild-type and cultured as
described (Brenner, 1974). Alleles used in this study included: LGI: lin-
59(n3168); lin-59(n3192); ced-1(e1735). LGII: rrf-3(pk1426). LGIII:
ceh-20(ay9); ceh-20(ay42); lin-39(n1760); unc-36(e251). LGIV: ced-3
(n717). LGV: unc-62(e644); unc-62(e917); unc-62(t2012); dpy-11
(e224); egl-1(n1084n3082). LGX: lin-15(n765); mxIs14, an integrated
Pegl-1histone:gfp transgene (Liu et al., 2006); mxIs28, an integrated
Pceh-20ceh-20:yfp transgene; mxIs31, an integrated Punc-62unc-62:cfp
transgene. deIs1 is an integrated, unmapped YAC-based Plin-39lin-39:
gfp transgene (Wagmaister et al., 2006). Lineage analysis was
performed as described previously (Sulston and Horvitz, 1977).
lin-59 alleles
Two partial loss-of-function alleles of lin-59 were identiﬁed in a
screen of mutagenized ced-1mutants (Cameron et al, 2002). We used
the rectal patterning defect of n3168mutants to identify n3168 homo-
zygotes, and found that 28 of 36 n3168 progeny of ced-1 n3168/++
animals were Ced, suggesting linkage to LGI. From n3168++/+dpy-5
unc-29 heterozygotes, 18 of 18 Unc-29 non-Dpy-5 recombinants
carried n3168. Zero of 24 Unc-11 non-Dpy-5 recombinants from
n3168++/+unc-11 dpy-5 heterozygotes carried n3168. 12 of 12
Lin-17 non-Unc-11 recombinants from +n3168+unc-29/lin-17+unc-
11+ heterozygotes carried n3168. In crosses of qDf3 and qDf4 males
into n3168 unc-29 hermaphrodites, we failed to obtain identiﬁable
non-Unc-29 cross progeny, suggesting that qDf3 and qDf4 delete
n3168, that n3168/Df animals die, and that the n3168mutation results
in a partial loss of lin-59 function. In all cases, the ventral nerve cord
cell corpse phenotype and rectal defect cosegregated. Sequencing
of lin-59 genomic DNA identiﬁed point mutations consistent with
EMS-induced changes that result in an R844Opal mutation (in n3168)
and a G616Amber mutation (in n3192).
RNAi and imaging
The screen for regulators of egl-1 expression was performed by
RNAi feeding of ced-1(e1735); ced-3(n717); mxIs14 or rrf-3(pk1426);ced-3(n717); mxIs14 mutants, as described (Fraser et al., 2000). L3-
stage progeny were observed using epiﬂuorescence and photo-
graphed by subtracting the rhodamine ﬁlter (emission 610–675)
image from the FITC band-pass ﬁlter image to reduce background
ﬂuorescence.
Reporter constructs
Reporter constructs were made using standard cloning techniques,
introduced into worms using microinjection, and integrated using
gamma irradiation. Pceh-20ceh-20:yfp was constructed identically to
Pceh-20ceh-20:cfp (Liu et al., 2006), except that yfp from pPD134.99
(a kind gift from Andy Fire, Stanford University, Palo Alto, CA, USA)
was cloned into the AscI restriction site. This construct rescued the Egl
phenotype of ceh-20(ay42)mutants (data not shown). It was injected
into ced-1; ced-3; lin-15 mutants at 50 ng/μL along with a lin-15
rescuing plasmid (50 ng/μL), integrated using gamma irradiation, and
back-crossed to N2 nine times. Punc-62unc-62:cfpwas constructed from
the cosmid T28F12 and the fosmid WRM061dC01 in several steps.
First, a 20 kb PmeI–SacII fragment from WRM061dC01 was inserted
into pBSKSII+ digested with SacII and SmaI (pMP040). Separately, a
12 kb SacII fragment from T28F12 was ligated into the SacII site of
pBSKSII+ (pMP041). A 2 kb fragment of pMP041 containing the stop
codon of unc-62 was PCR-ampliﬁed and cloned into pBSKSII+
(pMP042), and the stop codon was replaced with an AgeI restriction
site using site-directed mutagenesis (pMP043). The coding region of
cfp was PCR-ampliﬁed from pPD134.96 (a kind gift from Andy Fire)
and inserted into the AgeI site of pMP043 to produce pMP044. The
NheI–PacI fragment of pMP041 containing the unc-62 termination
codon was replaced with the 3 kb NheI–PacI fragment of pMP044,
essentially creating the unc-62:cfp fusion (pMP046). Finally, the 13 kb
SacII fragment from pMP046 was inserted into the SacII site of
pMP042 to produce the ﬁnal Punc-62unc-62:cfp plasmid, pMP062. This
construct contains 32 kb of the unc-62 genomic locus (including the
coding region, 14 kb of upstream sequence, and 4 kb of downstream
sequence) with a C-terminal cfp fusion, in the pBSKSII+ backbone.
pMP062 was injected at 10 ng/μL into lin-15(n765mat,ts) mutants
with a rescuing lin-15 construct at 50 ng/μL, and integrated using
gamma irradiation. The resulting animals were back-crossed to N2 six
times. All DNA fragments subjected to PCR ampliﬁcation were
completely sequenced.
Protein puriﬁcation and EMSA
Amino acids 141–229 of LIN-39 and 188–274 of CEH-20 were
puriﬁed from E. coli using the IMPACT™ Protein Puriﬁcation Kit (New
England Biolabs, Ipswich, MA, USA). EMSA binding reactions to a
biotinylated consensus Hox–Pbx probe (Liu and Fire, 2000) were
performed at room temperature for 30 min. in 1× TBB (10 mM Tris pH
7.5, 1 mM EDTA, 1 mMDTT, 0.1% NP-40, 5% glycerol), 500 ng poly dIdC,
200 ng LIN-39where included, 400 or 800 ng CEH-20where included,
20 fmol biotinylated Antp/Exd probe (Liu and Fire, 2000), and water
to 25 μL. The reactions were run on an 8% polyacrylamide native gel in
0.5× TBE (45 mM Tris-borate, 1 mM EDTA) at 4 °C and transferred to a
nylon membrane that was developed using the LightShift® Chemilu-
minescent EMSA Kit (Pierce, Rockford, IL, USA).
LIN-39 rescue assay
Pegl-1lin-39 constructs were assembled by precisely replacing the
histone:gfp insert of pMP001 (Pegl-1histone:gfp) (Liu et al., 2006) with
lin-39 cDNA. Site-directed mutagenesis was used to mutate W151 to F
or WM to AA. The repression domain of Engrailed (corresponding to
amino acids 1–298 of D. melanogaster protein) or the activation
domain of VP16 (corresponding to amino acids 413–490 of HSV-1
protein) was PCR-ampliﬁed with primers containing AgeI (5′) and
Table 1
Hox and Hox cofactor genes are required for cell survival and repression of egl-1/BH3
transcription in the midbody.
Genotype Anteriora Midbody Posterior
(A) Cell death
Number of corpses
unc-22(RNAi) 2.4±0.2 0.0±0.0 5.1±0.2
unc-22(RNAi); egl-1/BH3 0.0±0.0 0.0±0.0 0.0±0.0
lin-39/Hox(RNAi) 3.0±0.1 3.3±0.3 5.2±0.2
lin-39/Hox(RNAi); egl-1/BH3 0.0±0.0 0.0±0.0 0.0±0.0
ceh-20/Pbx(RNAi) 2.8±0.1 1.8±0.3 4.7±0.2
ceh-20/Pbx(RNAi); egl-1/BH3 0.0±0.0 0.0±0.0 0.0±0.0
unc-62/Meis(RNAi) 2.2±0.2 0.9±0.2 4.8±0.2
unc-62/Meis(RNAi) egl-1/BH3 0.0±0.0 0.0±0.0 0.0±0.0
lin-59/Ash1(RNAi) 2.6±0.1 2.8±0.2 3.4±0.3
lin-59/Ash1(n3192) 2.5±0.1 1.4±0.2 4.4±0.2
lin-59/Ash1(n3168) 2.9±0.1 1.7±0.2 4.4±0.1
lin-49(RNAi) 2.6±0.1 0.0±0.0 5.6±0.2
(B) egl-1/BH3 transcription
Number of nuclei expressing Pegl-1gfp
unc-22(RNAi) 3.9±0.2 0.0±0.0 6.8±0.1
lin-39/Hox(RNAi) 4.3±0.2 4.8±0.2 6.9±0.1
ceh-20/Pbx(RNAi) 4.9±0.2 4.8±0.3 6.0±0.2
unc-62/Meis(RNAi) 5.0±0.2 3.2±0.3 6.0±0.2
lin-39/Hox(n1760) 4.2±0.2 6.0±0.0 6.8±0.1
ceh-20/Pbx(ay9) 4.6±0.2 5.0±0.2 6.4±0.1
ceh-20/Pbx(ay42) 2.8±0.2 5.7±0.1 4.3±0.1
unc-62/Meis(e644) 2.6±0.2 0.2±0.1 6.6±0.1
unc-62/Meis(e917) 4.5±0.3 1.3±0.2 6.7±0.2
unc-62/Meis(t2012)b 1.9±0.2 0.7±0.1 4.4±0.2
(A) Number of corpses; mean±s.e.m. All strains were homozygous for ced-1(e1735).
The allele of egl-1 used was n1084n3082. n=18 for lin-59(RNAi), n=30 for all others.
(B) Numbers of nuclei expressing Pegl-1gfp; mean±s.e.m. Complete genotypes were as
indicated plus ced-3(n717); Pegl-1gfp. Rows one to ﬁve also included ced-1(e1735), row
seven included unc-36(e251), and row ten included dpy-11(e224). Animals were scored
as L3 larvae. n=30 for unc-22(RNAi); n=50 for all others.
a The anterior ventral nerve cord includes the retrovesicular ganglion, in which some
cells die embryonically (Sulston et al., 1983). The persistence of corpses in this region
through to the L3 larval stage is variable.
b Animals of this genotype exhibited extremely abnormal and variable body
morphology; as a result, nuclei numbers may be artiﬁcially low because the ventral
nerve cord was difﬁcult to identify.
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(3′) and AgeI (3′) sites, and a triple ligation was used to introduce
these fragments into the AgeI-digested pMP001. All constructs were
fully sequenced. These were injected into ced-1(e1735); lin-39(n1760)
animals at 50 ng/μL along with Pmyo-3gfp (50 ng/μL) as a coinjection
marker. Transgenic lines were identiﬁed by GFP ﬂuorescence, and at
least three independent lines per construct were scored for corpse
pattern in the ventral nerve cord. We were unable to perform similar
rescue experiments with ceh-20/Pbx and unc-62/Meis mutants
because of the lethality associated with loss-of-function of either
gene, as has been previously observed when attempting to construct
transgenic animals with these mutants (Van Auken et al., 2002).
Chromatin immunoprecipitation
Chromatin immunoprecipitations were performed using the anti-
AFP antibody (Qbiogene, Carlsbad, CA, USA) and quantiﬁed using real-
time PCR.
Chromatin preparation
Mixed stage Plin-39lin-39:gfp, Pceh20ceh20:yfp and Punc62unc62:cfp
animals were grown at 22.5 °C, harvested and ﬂash frozen with liquid
nitrogen. 600 μL of frozen worms was subsequently ground into ﬁne
powder with a mortar and pestle. The powder was washed once with
4 mL of ice-cold M9 buffer. 4 mL of 1% formaldehyde in M9 was used
for a 10 minute ﬁxation at room temperature, and then the reaction
was quenched for 5 minwith 1.714 mL of 1 M glycine. After 10 min on
ice, the extract was washed once with 4 mL of ice-cold M9 buffer and
twice with 4 mL of ice-cold FA Buffer (50 mM HEPES/KOH pH 7.5,
150 mM NaCl, 1 mM EDTA, 1% Triton X100, 0.1% Sodium deoxycho-
late). The extract was resuspended to 1.5 mL with ice-cold FA Buffer
plus 64 μL of 25× protease inhibitor cocktail (Roche, Tucson, AZ, USA)
and sheared to 100 bp 1000 bp size rangewith an Ultrasonic Processor
sonicator. An output of 8 Wwas used for sonication (ten cycles of 30 s
pulses followed by 2.5 min breaks in ice water). Cellular debris was
removed by centrifugation at 14,000 rpm for 30 min at 4 °C, and the
supernatant was frozen at −80 °C.
Immunoprecipitation
1 μg of anti-AFP antibody (Qbiogene, Carlsbad, CA, USA) or 1 μg of
mouse IgG (Innovative Research, Novi, MI, USA) and 25 μL of protein A
Sepharose beads (Carlsbad, CA, USA) were incubated in 275 μL of FA
Buffer for 2 h rotating at 4 °C. These beads were then washed with FA
Buffer three times and blocked with herring sperm DNA (200 μg/mL)
and BSA (0.1 mg/mL) in FA Buffer for 2 h rotating at 4 °C. The beads
werewashed with FA Buffer three times. The chromatinwas diluted in
6 mL of FA Buffer containing 1× protease inhibitor cocktail and pre-
cleared with 200 μL of 50% protein A Sepharose beads in FA Buffer
rotating at 4 °C for 2 h. The pre-cleared chromatin was centrifuged at
2000 rpm at 4 °C for 5 min. 10% of the supernatant was saved as input,
and the remaining material was divided into two equal volumes. IgG-
bound beads were added to one fraction of chromatin while anti-AFP-
bound beads were added to the other fraction, and both were
incubated overnight rotating at 4 °C.
DNA recovery
The beads were centrifuged at 2000 rpm at 4 °C for 5 min and then
sequentially washed at 4 °C with 1 mL of the following buffers: FA
Buffer with 0.1% SDS (5 min, 2×), FA Buffer with 1 M NaCl (5 min), FA
Buffer with 500 mM NaCl (10 min), TEL Buffer (0.25 M LiCl, 1% NP40,
1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris–HCl pH 8.0)
(10 min), and TE pH 8.0 (10 mM Tris pH 8.0, 1 mM EDTA) (5 min, 2×).
Complexes were eluted from the beads with 100 μL Elution Buffer
(50 mM Tris–HCl pH 7.5, 10 mM EDTA, 1% SDS) at 65 °C for 10 min.
After centrifugation at 2000 rpm at room temperature for 5 min, the
supernatant was added to 80 μL TE pH 7.5 and 20 μL proteinase K(20 mg/mL). Cross-linked polypeptides were digested at 42 °C for 2 h,
and cross-links were reversed overnight at 65 °C. 20 μL of 4 M LiCl was
added and the DNA was puriﬁed by phenol/chloroform extraction.
The DNA was dissolved in 35 μL of water and 2 μL was used for each
quantitative PCR reaction.
RNA extraction and quantitative PCR
RNA was extracted from mixed-stage worms using TRIzol®
Reagent, treated with DNase I (Invitrogen, Carlsbad, CA, USA) and
converted to cDNA using the High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems, Foster City, CA, USA). An amount of cDNA
corresponding to 50 ng of input RNA was used for each quantitative
PCR reaction. Quantitative PCRwas performed using the delta-delta Ct
method with Power SYBR® Green PCR Master Mix (Applied Biosys-
tems, Foster City, CA, USA) on a 7900HT Fast Real-Time PCR System
(Applied Biosystems) according to the manufacturer's instructions.
Results
The trithorax-group gene lin-59/Ash1 is required for survival of the VC
motor neurons
Hox transcription is controlled by many factors including the
opposing activities of polycomb- and trithorax-group genes, which
generally maintain the repressed and activated states of transcription,
respectively (Schuettengruber et al., 2007). In a screen for genes that
Fig. 1. The trithorax-group gene lin-59/Ash1 is required for VC survival and maintenance of lin-39/Hox mRNA levels. (A) The P3–P8 cell lineages of wild-type animals (Sulston and
Horvitz, 1977). Horizontal lines represent cell divisions and vertical lines representing time. Pn.aap cells (the posterior daughters of the anterior daughters of the anterior daughters
of P cells) survive and become VC neurons, indicated by open circles. (B) Cell lineages of four lin-59(n3168) mutants. Arrows highlight programmed cell deaths (X). Open circles
indicate Pn.aap cells that survive. (C) qRT-PCR was used to quantitate mRNA levels of lin-39/Hox and two control genes from animals of the indicated genotypes. Error bars represent
s.e.m. (D) Relative mRNA levels from control unc-22(RNAi) and lin-59/Ash1(RNAi) animals. (E) Relative mRNA levels of ceh-20/Pbx and two controls from mutants of the indicated
genotypes. In (C–E), data are normalized to inf-1 and expressed as average fold-change versus wild-type.
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et al., 2002), we identiﬁed two alleles of the trithorax-group gene lin-
59, which encodes a SET domain-containing protein homologous to
the Drosophila Ash1 and human Ash1L histone methyltransferases
(Chamberlin and Thomas, 2000). lin-59(n3192) and lin-59(n3168)
encode premature stop codons that are predicted to truncate the
protein just N-terminal and just C-terminal to the SET domain,
respectively (Supplemental Fig. 1). Genetic analyses suggest that both
alleles result in partial loss of gene function (see Materials and
methods).
To study the effect of lin-59/Ash1 loss on the pattern of
programmed cell deaths, we used ced-1(e1735) mutants in which
most dying cells persist as visible corpses. In an otherwise wild-type
ced-1 background, corpses are visible in the anterior and posterior
regions of the ventral cord where cell deaths occur, but never in the
midbody region where all cells survive (Sulston, 1976). Whereas
control unc-22(RNAi) does not alter this wild-type pattern, lin-59/
Ash1 mutants and lin-59/Ash1(RNAi) animals exhibit cell corpses in
the midbody region of the ventral nerve (Table 1A). Analysis of celllineages of the P3-P8 blast cells in four lin-59(n3168) animals
conﬁrmed programmed cell death of the VC neurons (Figs. 1A, B).
Thus survival of the VC neurons requires lin-59/Ash1.
lin-59/Ash1 promotes transcription of lin-39/Hox
lin-59/Ash1 regulates expression of the posterior Hox genesmab-5
and egl-5 (Chamberlin and Thomas, 2000). We therefore investigated
whether lin-59/Ash1 promotes VC neuron survival by maintaining
transcription of the midbody Hox gene lin-39, which ensures survival
of the VC neurons through unknownmechanisms (Table 1A) (Clark et
al., 1993). Because the Plin-39gfp reporter is extremely dim even in
wild-type animals, we used quantitative PCR to compare lin-39/Hox
transcript levels in the presence and absence of lin-59. We found
decreased lin-39/HoxmRNA in lin-59(RNAi), lin-59(n3168) and lin-59
(n3192) mutants compared to wild-type animals (Figs. 1C, D). mRNA
levels of the Hox cofactor ceh-20/Pbx and two controls were normal in
lin-59/Ash1 mutants (Fig. 1E). These data suggest that lin-59/Ash1
promotes VC survival by maintaining mRNA levels of lin-39/Hox.
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To discover additional genes that regulate VC survival we used a
gfp reporter of egl-1/BH3 transcription and RNAi of candidate genes
to identify genes that contribute to the normal pattern of programmed
cell death in the ventral nerve cord. The BH3-only gene egl-1 is
required for programmed cell death of somatic cells of C. elegans and
is transcriptionally regulated to control the survival or death of
speciﬁc cells (Conradt and Horvitz, 1998, 1999; Liu et al., 2006;
Thellmann et al., 2003). We developed a transcriptional reporter of
egl-1/BH3 by integrating a Pegl-1histone:gfp transgenic construct, in
which the open reading frame of egl-1/BH3 is precisely replaced with
sequences encoding a histone:gfp fusion (seeMaterials andmethods),
into ced-3/caspase mutants (Liu et al., 2006). In this strain, which we
refer to as Pegl-1gfp, the ced-3/caspase mutation prevents cell death,
and a histone:gfp fusion gene is expressed under control of the egl-1/
BH3 regulatory region.
In Pegl-1gfp hermaphrodites the pattern of GFP expression precisely
matched the pattern of programmed cell deaths in the midbody andFig. 2. unc-62/Meis, lin-39/Hox, and ceh-20/Pbx are required for egl-1/BH3 repression and su
The anterior, midbody, and posterior regions are indicated. X: cells that undergo programmed
h) images of L3-stage hermaphrodites carrying the Pegl-1gfp reporter and exposed to the indic
that survive inwild-type animals. Only ﬂuorescent cells of the ventral nerve cord are highligh
P5 and P6 cell lineages of wild-type animals, in which P5.aap and P6.aap survive and differen
ﬁve N2 animals exposed to unc-62/Meis(RNAi). Cells that underwent programmed cell deat
lineages in the escapers. (E) DIC image of an animal in which both P5.aap and P6.aap died.posterior regions of the ventral nerve cord (shown schematically in
Fig. 2A). Speciﬁcally, all cells that undergo programmed cell death in
wild-type animals expressed GFP, and all cells that survive in wild-
type animals did not (data not shown). This suggests that the pattern
of programmed cell death and survival in these regions is largely
determined by controlling transcription of egl-1/BH3, and that the
Pegl-1gfp reporter accurately portrays the wild-type pattern of egl-1/
BH3 expression.
To identify genes that determine the egl-1/BH3 expression pattern,
we screened transcription factors with RNAi phenotypes of sterility or
lethality (60 total) from the published genome-wide RNAi screen
datasets (Kamath et al., 2003), reasoning that such genes might have
been missed in conventional mutagenesis screens, which generally
have not been designed to recover lethal or sterile alleles. As RNAi has
a spectrum of gene inactivation in a population of animals, allowing
the survival of animals that escape complete inactivation, it can be
used to identify and analyze the consequences of partial loss of gene
function. Control unc-22(RNAi) did not alter the wild-type pattern of
egl-1/BH3 expression, but unc-62/Meis(RNAi) resulted in ectopicrvival of the VC neurons. (A) Lineages of the ventral nerve cord are shown schematically.
cell death. Green circles: VCmotor neurons. (B) DIC (a,c,e,g) and epiﬂuorescence (b,d,f,
ated RNAi. Open arrowheads: cells that die inwild-type animals. Filled arrowheads: cells
ted. Scale bar in (a) applies to all panels. Anterior is leftwards, ventral is downwards. (C)
tiate into VC neurons (Sulston and Horvitz, 1977). (D) Lineages of the P5 and P6 cells of
h are indicated by an X and highlighted by arrows. unc-62(RNAi) is lethal; we followed
Arrows highlight the two corpses.
Fig. 3. LIN-39/Hox cooperates with CEH-20/Pbx and represses transcription to promote VC survival. (A) Schematic of lin-39/Hox rescue assay. Inwild-type animals (left column), lin-
39/Hox represses egl-1/BH3 in the VC neurons, and the cells live. In lin-39/Hox mutants (middle column), egl-1/BH3 transcription is initiated and the VC neurons die shortly after
being born. To rescue VC death in the lin-39/Hoxmutant animals (right column), we introduced Pegl-1lin-39 to drive lin-39/Hox cDNA from the egl-1/BH3 promoter. In these worms,
lin-39/Hox transcription (from the transgene) and egl-1/BH3 transcription (from the endogenous locus) are concurrently initiated in the VC neurons, but subsequent production of
functional LIN-39/Hox leads to repression of egl-1/BH3 and a reduction in VC cell death. (B) Electrophoretic mobility shift assay (EMSA) was performed using a Pbx/Hox consensus
probe and puriﬁed LIN-39/Hox and CEH-20/Pbx protein fragments. Increasing quantities of CEH-20/Pbx were added to a ﬁxed amount of LIN-39/Hox. (C) Number of corpses was
scored in three regions of the ventral nerve cord in ced-1(e1735) animals; anterior (W, P1, and P2 descendants), midbody (P3–P8 descendants) and posterior (P9–P12 descendants).
The ability of wild-type LIN-39, LIN-39(WNF) and LIN-39(WMNAA) to rescue VC death in the lin-39/Hoxmutant was examined. Bars represent corpse number±s.e.m. (D) Using the
same assay, the rescuing abilities of Engrailed:LIN-39 and VP16:LIN-39 were tested. For C and D, at least three independent lines (20 worms per line) were scored per transgene (see
Supplemental Fig. 4 for data from individual lines).
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(Fig. 2B, Table 1B). The partial loss-of-function alleles unc-62(e917)
and unc-62(t2012) also result in ectopic egl-1/BH3 expression in the
midbody (Table 1B). Mutants completely lacking unc-62/Meis gene
function exhibit complete embryonic lethality and therefore could not
be examined (Van Auken et al., 2002).
unc-62/Meis ensures survival of the VC motor neurons
To determine whether ectopic egl-1/BH3 transcription resulted in
the death of cells that normally survive, we used the ced-1(e1735)
background. Control unc-22(RNAi) does not alter the normal pattern
of programmed cell deaths, but unc-62/Meis(RNAi) results in ectopic
corpses in the midbody region of the ventral nerve cord (Table 1A,
Supplemental Fig. 2). This phenotype is also observed in unc-62(e917)
and unc-62(t2012) mutants (Supplemental Figs. 2C, D). We observed
the lineages of the P5 and P6 blast cells in ﬁve unc-62/Meis(RNAi)
animals to determine which cells require unc-62/Meis for survival,
and found that four of ten Pn.aap cells died (Figs. 2C–E). In wild-type
animals, the Pn.aap cells invariably survive and differentiate into VC
motor neurons (Sulston, 1976). Therefore, unc-62/Meis, like lin-59/
Ash1 and lin-39/Hox, is required for survival of the VC neurons.
lin-39/Hox and ceh-20/Pbx promote VC survival through transcriptional
repression of egl-1/BH3
Previous work has shown that survival of the VC neurons requires
the Hox gene lin-39 and the Hox cofactor ceh-20/Pbx, which act
upstream of egl-1/BH3 through unknown mechanisms (Clark et al.,
1993; Liu et al., 2006). Because homologs of UNC-62/Meis interact
genetically and biochemically with Pbx and Hox homologs (Moens
and Selleri, 2006), we considered the possibility that lin-39/Hox, ceh-
20/Pbx, and unc-62/Meis act together to repress egl-1/BH3 andFig. 4. LIN-39/Hox and CEH-20/Pbx bind to the egl-1/BH3 locus at multiple sites in vivo. (A)
BH3 genomic locus. Their location within the 7.66 kb minimal rescuing fragment of egl-1/BH
(B) Chromatin immunoprecipitation (ChIP) was performed on animals carrying the Plin-39lin
quantitated by real-time PCR using the indicated egl-1/BH3 primer sets or an irrelevant cont
(C, D) ChIP was repeated as in (B) using worms carrying the Pceh-20ceh-20:yfp rescuing repo
shown from at least three independent experiments.prevent death of the VC neurons. Indeed, reduction of lin-39/Hox or
ceh-20/Pbx function by RNAi or mutation results in ectopic Pegl-1gfp
expression in the VC neurons (Fig. 2B; Table 1B), suggesting that like
unc-62/Meis, lin-39/Hox and ceh-20/Pbx promote VC survival by
repressing egl-1/BH3 transcription.
lin-39/Hox likely acts cell-autonomously to prevent death of the VC
neurons
If LIN-39/Hox, CEH-20/Pbx, and UNC-62/Meis directly bind egl-
1/BH3 to repress transcription in the VC neurons, then all three
proteins should be expressed there and function in a cell-autono-
mous fashion. LIN-39/Hox is present in neurons in the midbody
region of the ventral nerve cord (Maloof and Kenyon, 1998;
Wagmaister et al., 2006), and rescuing transgenic reporter constructs
suggest that ceh-20/Pbx and unc-62/Meis are broadly expressed in
all nuclei in the ventral nerve cord, including the VC neurons (Liu et
al., 2006; Yang et al., 2005) (Supplemental Fig. 3). Because each of
these genes is expressed in the VC neurons and other cells, we
considered the possibility that they may act nonautonomously to
prevent VC death, for example by affecting the fates of other ventral
nerve cord motor neurons. lin-39 mutants crawl normally, however,
suggesting that the VA and VB motor neurons, which are required for
backwards and forwards movement, are not obviously abnormal. We
also examined expression of two markers of VA and VB fate, Punc-4gfp
and Pdel-1gfp. Both markers were expressed normally in Punc-4gfp and
Pdel-1gfp transgenic animals in which lin-39 was inactivated by RNAi.
Speciﬁcally, we counted 10.7 ﬂuorescent neurons in the ventral nerve
cord of L2 stage Punc-4gfp; lin-39(RNAi) animals compared to 10.6
ﬂuorescent neurons in control Punc-4gfp; unc-22(RNAi) animals.
Similarly, we counted 14.9 ﬂuorescent neurons in the ventral nerve
cord of L2 stage Pdel-1gfp; lin-39(RNAi) animals compared to 14.6
ﬂuorescent neurons in control Pdel-1gfp; unc-22(RNAi) animals. TheseFour primer sets (1–4) were designed to recognize widely-spaced regions of the egl-1/
3 is shown. Asterisks denote evolutionarily conserved consensus Hox–Pbx binding sites.
-39:gfp construct, using anti-AFP antibody or control IgG. Immunoprecipitated DNAwas
rol (mig-32). Results are plotted as fold-enrichment of anti-AFP IP versus control IgG IP.
rter and the Punc-62unc-62:cfp rescuing reporter. The average fold-enrichment±s.e.m is
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obviously altered in the absence of lin-39. To directly ask whether
targeting lin-39/Hox expression speciﬁcally to the VC neurons can
prevent VC death, we introduced a Pegl-1lin-39 transgene into ced-1;
lin-39 mutants and counted cell corpses in the ventral nerve cord
(Fig. 3A). Indeed, four independent transgenic lines showed similar
levels of rescue in the midbody (Supplemental Fig. 4, Fig. 3C).
Because endogenous LIN-39/Hox is limited to the midbody region
(Maloof and Kenyon, 1998; Wagmaister et al., 2006) and the egl-1/
BH3 promoter is expressed only in the VC neurons of the ventral
nerve cord in this region in lin-39/Hox mutants (Fig. 2B and Table
1B), these data suggest that lin-39/Hox acts cell-autonomously to
ensure survival of the VC neurons.
A LIN-39/Hox–CEH-20/Pbx complex ensures VC survival
LIN-39/Hox contains a conserved hexapeptide motif N-terminal to
the homeodomain (Clark et al., 1993), which in homologous proteins
is required for binding to the Pbx cofactor but not for DNA binding or
protein stability in vitro or in vivo (Chang et al., 1995; Knoepﬂer and
Kamps, 1995; Neuteboom et al., 1995; Phelan and Featherstone, 1997;
Phelan et al., 1995). We created two LIN-39/Hox mutant proteins in
which the critical tryptophan of the hexapeptide was mutated, LIN-
39/Hox(WNF) and LIN-39/Hox(WMNAA), expressed and puriﬁed
these proteins from E. coli, and tested their function in an electro-
phoretic mobility shift assay (EMSA). Wild-type LIN-39/Hox efﬁ-
ciently bound a consensus Hox–Pbx probe and cooperated with CEH-
20/Pbx in a dose-dependent manner (Fig. 3B, lanes 1–4). As expected,
both mutant proteins bound DNA as well as wild-type, but failed to
cooperate with CEH-20/Pbx (Fig. 3B, lanes 5–10).Fig. 5. unc-62/Meis is required for nuclear localization of CEH-20/Pbx. L3-stage hermaphro
using DIC (E, C, E, G) or ﬂuorescence (B, D, F, H) optics. (A, B) CEH-20/Pbx is highly enriche
nucleus is outlined inwhite and highlighted by an arrow. Nucleoli are prominent in the hypod
results in loss of nuclear localization of CEH-20/Pbx in the lateral hypodermal cells. A single nu
localization in the ventral nerve cord of worms fed control unc-22(RNAi). (G, H) In worms fe
cells of the ventral nerve cord. 97 of 97 neuronal nuclei in the ventral nerve cord of Pceh-20ceh-
nuclei of Pceh-20ceh-20:yfp; unc-62/Meis(RNAi) lacked nuclear ﬂuorescence completely andWe used the lin-39/Hox in vivo rescue assay described above to
determine whether these mutant proteins were able to prevent death
of the VC neurons. We found that although expression of wild-type
lin-39/Hox(+) cDNA in the VC neurons rescued their death, lin-39/
Hox(WNF) or lin-39/Hox(WMNAA) cDNA did not (Fig. 3C, Supple-
mental Fig. 4). This suggests that a LIN-39/Hox–CEH-20/Pbx complex
represses egl-1/BH3 transcription to ensure VC neuron survival.
LIN-39/Hox likely acts as a transcriptional repressor to prevent cell death
Hox proteins can function as transcriptional activators or repres-
sors (Moens and Selleri, 2006). To determine whether lin-39 acts as a
repressor or activator to prevent cell death, we fused lin-39/Hox
coding sequences to the activation domain of VP16 or the repression
domain of Engrailed (Jaynes and O'Farrell, 1991; Sze et al., 1997) and
tested these fusion constructs using the rescue assay described above.
Engrailed:LIN-39 promoted VC survival much more efﬁciently than
VP16:LIN-39, suggesting that LIN-39/Hox functions as a transcrip-
tional repressor to prevent death of the VC neurons in wild-type
animals (Fig. 3D, Supplemental Fig. 4). This ﬁnding is consistent with
direct repression of egl-1/BH3 transcription by a LIN-39/Hox–CEH-
20/Pbx complex in the VC neurons.
Ectopic lin-39/Hox expression can prevent programmed cell death
The rescue assay used above drives lin-39/Hox expression in all
cells that express egl-1/BH3, including cells outside the midbody
region to which lin-39/Hox expression is normally restricted (Wag-
maister et al., 2006; Wang et al., 1993). In the posterior region of the
ventral nerve cord (P9–P12 descendants), seven cells undergodites expressing a rescuing translational reporter for CEH-20/Pbx were photographed
d in the nuclei of lateral hypodermal cells in animals fed control unc-22(RNAi). A single
ermal cells and CEH-20/Pbx is relatively excluded from them. (C, D) unc-62/Meis(RNAi)
cleus is outlined inwhite and highlighted byan arrow. (E, F) CEH-20/Pbx shows nuclear
d RNAi to unc-62/Meis, nuclear CEH-20/Pbx is variably lost in neurons and hypodermal
20:yfp; unc-22(RNAi) animals were obviously ﬂuorescent, whereas eight of 104 neuronal
most others showed diminished nuclear ﬂuorescence. Scale bars represent 10 μm.
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corpses are observed in both ced-1 and ced-1; lin-39mutants (Fig. 3C)
(Clark et al., 1993). Remarkably, expression of Pegl-1lin-39 or
Pegl-1Engrailed:lin-39 suppressed programmed cell death in the
posterior ventral cord (Fig. 3D). This implies that ectopic expression
of LIN-39/Hox in cells that normally die in wild-type animals can
repress egl-1/BH3 through cooperationwith CEH-20/Pbx, blocking an
intrinsic mechanism for programmed cell death that normally kills
these cells.
egl-1/BH3 repression in the VC neurons requires multiple redundant
sites
The results described would be consistent with direct repression of
egl-1/BH3 transcription by a LIN-39/Hox–CEH-20/Pbx complex in the
VC neurons. If this hypothesiswere correct, wewould expect to ﬁnd one
or more Hox/Pbx consensus sites in the promoter of egl-1/BH3 that are
required for repression in the VCs. The minimal fragment of the egl-1/
BH3 genomic locus required for rescueof the correct cell deathpattern in
the ventral nerve cord of egl-1/BH3mutant animals is 7.66 Kb long,with
the majority of the regulatory region lying 3′ to the egl-1/BH3 open
reading frame (Fig. 4A) (Liu et al., 2006). A search for consensus Hox/
Pbxbinding sites in the promoter identiﬁes 116matches, ofwhich12 are
conservedbetweenC. elegans,C. remaneii, andC. briggsae, threedistantly
related nematode species. The locations of the 12 conserved sites are
indicated by asterisks in Fig. 4A. We disrupted all 12 conserved sites by
site-directed mutagenesis in a single Pegl-1gfp construct. The resulting
construct was correctly repressed in the VC neurons (data not shown),
suggesting that either LIN-39/CEH-20 represses egl-1/BH3 indirectly
through non-Hox consensus binding sequences, or it binds one or more
of the remaining 104 sites.
To attempt to identify a single region of egl-1/BH3 that is required
for repression in the VCs, whether bound by a LIN-39/Hox–CEH-20/
Pbx complex or by another hypothetical transcription factor, we made
a series of six deletion mutants that systematically removed 1 kb
segments of egl-1/BH3 sequence, covering the entire noncoding
region of egl-1/BH3. Each of these deletion mutants was correctly
repressed in the VC neurons, suggesting that the factor or factors that
repress egl-1/BH3 in the VC neurons bind and act through multiple,
dispersed and redundant sites (data not shown).
LIN-39/Hox and CEH-20/Pbx bind the egl-1/BH3 locus at multiple sites
in vivo
We used chromatin immunoprecipitation (ChIP) to determine
whether LIN-39/Hox, CEH-20/Pbx, and UNC-62/Meis were enriched
at the egl-1/BH3 genomic locus in vivo. We performed immunopreci-
pitation of protein-cross-linked-DNA from the Plin-39lin-39:gfp strain
(Wagmaister et al., 2006) with anti-All Fluorescent Protein (anti-AFP)
antibody or IgG control and used quantitative PCR to compare the
amount of egl-1/BH3 DNA bound to each. Primers designed toward
widely separated regions of egl-1/BH3 showed weak but reproducible
enrichment, suggesting that LIN-39/Hox binds to egl-1/BH3 at multi-
ple, dispersed sites (Fig. 4B). Primers designed toward a control genetic
locus not known to be regulated by Hox genes did not show repro-
ducible enrichment, suggesting that the immunoprecipitation speci-
ﬁcally brought down DNA associated with the LIN-39:GFP fusion
protein. ChIP experiments using the same antibody were performed
with the Pceh-20ceh-20:yfp and Punc-62unc-62:cfp rescuing translational
fusions to examine CEH-20/Pbx and UNC-62/Meis associationwith the
egl-1/BH3 locus.We observed reproducible enrichment of CEH-20/Pbx,
but not UNC-62/Meis, at several sites along the egl-1/BH3 promoter
(Figs. 4C, D). These results, taken together with those described above,
suggest that a complex composed of LIN-39/Hox andCEH-20/Pbxbinds
the egl-1/BH3 regulatory region at multiple dispersed, redundant sites
to repress egl-1/BH3 transcription in the VC neurons.unc-62/Meis is required for nuclear localization of CEH-20/Pbx
Becausewe did not observe enrichment of UNC-62/Meis at the egl-
1/BH3 locus, we asked whether this protein might be involved in egl-
1/BH3 repression in a less direct manner. In Drosophila, the unc-62/
Meis homolog Homothorax is required for nuclear localization of the
ceh-20/Pbx homolog Extradenticle (Stevens and Mann, 2007), and
one report in C. elegans suggests the samemay be true in this organism
as well (Van Auken et al., 2002). We therefore examined the
subcellular localization of CEH-20/Pbx in animals carrying the
Pceh-20ceh-20:yfp reporter. In control unc-22(RNAi) animals, CEH-20/
Pbx was localized in the nuclei of cells where it was expressed, which
included the lateral hypodermal cells (Fig. 5B) and all nuclei of the
ventral nerve cord (Fig. 5F). However, in unc-62/Meis(RNAi) animals,
nuclear localization was lost in the lateral hypodermal cells (Fig. 5D)
andwas absentor variable inmanyneuronal nuclei in the ventral nerve
cord (Fig. 5H). The discrepancy in severity of the defect in nuclear
localization we observed between hypodermal cells and neurons may
be due to reduced efﬁciency of RNAi in neuronal cells compared tonon-
neuronal cells in C. elegans (Simmer et al., 2002). These data suggest
that unc-62/Meis contributes to egl-1/BH3 repression and VC survival
by promoting nuclear localization of CEH-20/Pbx.
Further evidence supporting a role for unc-62/Meis in promoting
CEH-20/Pbx function comes from analysis of ceh-20/Pbx transcript
levels (Fig. 1E). Surprisingly, ceh-20/Pbx mRNA levels are increased
in ceh-20/Pbx partial loss-of-function mutants compared to wild-
type controls, suggesting that ceh-20/Pbx transcription is controlled
in part by a self-regulatory negative feedback mechanism. The levels
of ceh-20/Pbx mRNA are also increased in unc-62/Meis mutants
compared to wild-type controls, suggesting that unc-62/Meis is
required for proper ceh-20/Pbx function in the context of this
negative feedback mechanism.
These data suggest that a complex composed of LIN-39/Hox and
CEH-20/Pbx directly binds egl-1/BH3 and represses its transcription.
This activity depends on unc-62/Meis for nuclear localization of CEH-
20/Pbx, and on lin-59/Ash1 for maintenance of lin-39/Hox mRNA
levels. Survival of the VC motor neurons requires the activity of these
four genes, and the ultimate mechanism through which they promote
cell survival is through Hox-mediated transcriptional repression of the
BH3-only gene egl-1.
Discussion
Here we describe the mechanism through which four genes
cooperate to prevent programmed cell death of the VC neurons of C.
elegans. The Hox transcription factor LIN-39 and the TALE-class
cofactor CEH-20/Pbx cooperate to repress egl-1/BH3 transcription
and prevent programmed cell death. Two novel regulators of
programmed cell death, the trithorax-group gene lin-59/Ash1L and
the TALE-class cofactor unc-62/Meis, promote cell survival by main-
taining lin-39/Hox transcript levels and facilitating nuclear localization
of CEH-20/Pbx, respectively. Loss of any of these four genes results in
egl-1/BH3 expression and programmed cell death. Our data are
consistent with direct repression of egl-1/BH3 transcription by a LIN-
39/Hox–CEH-20/Pbx complex, but do not show this conclusively. Our
ChIP data suggest that CEH-20/Pbx and likely LIN-39/Hox can bind
egl-1 in vivo. However, because ChIP in C. elegans surveys chromatin
binding in whole animals it cannot distinguish whether this complex
forms on egl-1/BH3 in the VC neurons or in other cells.
Hox-mediated inhibition of programmed cell death in the VC
neurons contrasts with previous work identifying a distinct Hox–Pbx
complex that promotes programmed cell death of a different cell, P11.
aaap (Liu et al., 2006). In P11.aaap, the more posterior Hox protein
MAB-5 binds the egl-1/BH3 promoter cooperatively with CEH-20/Pbx
to activate transcription, resulting in cell death. In the absence of
MAB-5 or CEH-20, or with mutations in egl-1/BH3 regulatory DNA
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egl-1/BH3 is not expressed and P11.aaap survives. It is not clear how
two distinct Hox–Pbx heterodimers, LIN-39-CEH-20 in the VC neurons
and MAB-5-CEH-20 in P11.aaap, exert opposite effects on egl-1/BH3
transcription. lin-39/Hox is active in the midbody and mab-5/Hox in
the posterior. The transcriptional outcome could be determined solely
by which Hox protein is expressed and incorporated into the
heterodimer. Alternatively, the Hox proteins could be functionally
interchangeable and directly recruit transcriptional coactivators and
corepressors that are active in the different cells, or could recruit these
factors indirectly through other cell type-speciﬁc factors with which
the Hox protein complexes interact. We observed that expression of
LIN-39/Hox outside its normal domain is sufﬁcient to prevent
programmed cell death in some cells, suggesting that it can engage
a mechanism in posterior cells that blocks cell death; this mechanism
also requires interaction with CEH-20/Pbx. In contrast, ectopic
expression of MAB-5/Hox does not affect the pattern of programmed
cell death (Salser et al., 1993), suggesting that repression of cell death
by LIN-39/Hox and promotion of cell death by MAB-5/Hox in part
reﬂects intrinsic differences in the functional interactions mediated by
the speciﬁc Hox proteins with other cell type-speciﬁc factors.
Hox, Pbx, Meis, and Trithorax-group proteins cooperate to induce
acute myelogenous and acute lymphoblastic leukemia in humans and
mouse models through mechanisms that are not yet well understood,
as recently reviewed (Sitwala et al., 2008). Published work describing
the mechanisms that decide whether individual cells of C. elegans
survive or undergo programmed cell death have revealed a remark-
able correlation between regulators of cell death in C. elegans and
human oncogenesis. Seven of the nine genes previously identiﬁed that
directly regulate the cell death decision are C. elegans homologs of
human oncogenes, and here we extend this by identifying unc-62/
Meis, the homolog of which is an essential cofactor in many human
leukemias (Sitwala et al., 2008; Wong et al., 2007). The human
ortholog of lin-59, Ash1L, is not clearly an oncogene in leukemias, but
shares with MLL the essential function of histone H3K4 modiﬁcation
to promote Hox gene expression (Chamberlin and Thomas, 2000;
Milne et al., 2002; Nakamura et al., 2002). The correlation between
genes that regulate cell survival in C. elegans and those that act as
human oncogenes suggests that transcriptional repression of apopto-
sis may be an essential function of oncogenic transcription factors that
has been selected for in cancers. Moreover, we suggest that the
mechanism we describe here, in which a trithorax-group protein acts
through a Hox complex to ensure survival of speciﬁc cells, is a model
for one aspect of how Hox overexpression promotes leukemia.
Speciﬁcally, activation of Hox complex activity may promote leukemia
in part through transcriptional repression of a BH3-only gene,
preventing apoptosis of abnormal hematopoietic or leukemic cells.
In support of this idea, mice with mutations affecting BH3-only genes
develop hematological malignancies, suggesting that abnormal
repression of BH3-only gene expression could promote leukemogen-
esis (Egle et al., 2004; Ranger et al., 2003; Zinkel et al., 2003).
The mechanisms through which Hox complex activation results in
leukemia are well studied but important questions remain. Fusions
involving the trithorax-group gene MLL result in overexpression of
several Hox genes and cofactors and cause leukemia, but which Hox
targets have causative roles in this process, and a mechanistic
understanding of those roles, are poorly understood (Argiropoulos
et al., 2007; Armstrong et al., 2002; Ayton and Cleary, 2003; Kumar et
al., 2004;Wong et al., 2007). Concurrent overexpression of HoxA9 and
Meis1 is sufﬁcient to cause leukemia in mouse models (Kroon et al.,
1998), and overexpression of HoxA9 and Meis1 are poor prognostic
indicators in human leukemia (Afonja et al., 2000; Golub et al., 1999;
Serrano et al., 2006). Although Meis1 is required for MLL fusion-
induced leukemia in mouse models, HoxA9 may not be, probably
because of redundancy with other Hox proteins (So et al., 2004). Until
recently, Pbx proteins were not thought to be essential; however,recent experiments show that concurrent depletion of Pbx2 and Pbx3
results in the inability of MLL fusions to cause leukemia (Wong et al.,
2007). How Hox, Pbx, and Meis proteins collaborate to induce
leukemia is not known (Sitwala et al., 2008). Because leukemia cells
express many Hox, Pbx and Meis cofactor genes with at least some
redundant functions, loss-of-function approaches to assess the role of
individual genes are problematic. The relative simplicity of the Hox
complex in C. elegans, with six genes (Aboobaker and Blaxter, 2003),
and a single Pbx family member with a role in programmed cell death
in the ventral nerve cord (Liu et al., 2006), made it possible for us to
deﬁne a mechanism of regulation of a single target gene that controls
a process, programmed cell death, important in oncogenesis.
To develop improved therapies the molecular mechanisms that
maintain the transformed phenotype must be identiﬁed; these are
likely to be cell type and gene-speciﬁc, as we describe here for
regulation of egl-1/BH3 in the VC neurons. If Hox protein complexes
repress pro-apoptotic BH3-only genes in leukemias, then disruption of
this mechanism may induce apoptosis of leukemia cells outright or
may sensitize them to other apoptosis-inducing therapies. Strikingly,
our results immediately suggest one potential strategy for disrupting
Hox-mediated BH3 repression. Disrupting the interaction between
LIN-39/Hox and CEH-20/Pbx by mutation of a critical tryptophanwas
sufﬁcient to prevent the ability of LIN-39 to promote cell survival, both
in the VC neurons where LIN-39 is endogenously expressed, and in
other cells where ectopic expression of LIN-39 otherwise prevents
naturally occurring cell death. Arguably, the latter situation may be
analogous to leukemia cells where Hox expression has been artiﬁcially
elevated through chromosomal translocations or other means.
In conclusion, we have demonstrated that a Hox complex
promotes cell survival by repressing transcription of the BH3-only
gene egl-1 in the VC neurons of C. elegans. We suggest that activation
of Hox complex activity results in transcriptional repression of human
BH3-only genes, and that this process may be critical for the survival
of this speciﬁc subset of leukemia cells. If so, this mechanism may
represent a promising new therapeutic target for treatment of these
leukemias.
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